The clinical performance is complex and often involves multiple systemic burdens. Early identification and standardised clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging checks, laboratory tests and pathological evaluation.
The platform can assist in linking a team of nationally and internationally authoritative experts to provide accurate diagnostics and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, significant improvements have been made in many previously difficult to treat genetic metabolic diseases. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule according to the changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of pathogenic high-herbic acid urethritis. The platform serves a team of domestic and foreign experts in the field of genetic metabolism linked to the China International Medical Service System, providing the following services to patients: 1. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.